CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...